Acesion Pharma

Acesion Pharma

Produktion af lægemidler

Copenhagen, Capital Region 2.202 følgere

Danish biotech developing novel treatments for Atrial Fibrillation

Om os

Acesion Pharma is a Danish biotech company founded in 2011. We are aiming to develop more efficacious and safer drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The scientific foundation of Acesion Pharma is the novel concept of treating AF by inhibiting the so-called SK channels. These are ion channels present in the heart where they are relevant for regulating the cardiac rhythm. Blocking this ion channel with a selective drug molecule constitutes a novel and promising target for developing improved treatment of AF.

Branche
Produktion af lægemidler
Virksomhedsstørrelse
11-50 medarbejdere
Hovedkvarter
Copenhagen, Capital Region
Type
Privat
Grundlagt
2011

Beliggenheder

  • Primær

    Ole Maaløes Vej 3

    Copenhagen, Capital Region 2200, DK

    Se ruten

Medarbejdere hos Acesion Pharma

Opdateringer

Tilsvarende sider

Finansiering

Acesion Pharma 7 runder i alt

Seneste runde

Serie B

47.561.169,00 US$

Læs mere på crunchbase